Application in France of the 2021 European recommendations on endometrial cancer

groupe SFOG et SFOG campus

doi:10.1016/j.bulcan.2022.11.003

Application in France of the 2021 European recommendations on endometrial cancer

Titre traduit de la contribution: Application en France des recommandations européennes 2021 sur le cancer de l'endomètre

groupe SFOG et SFOG campus

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

2 Citations (Scopus)

Résumé

The latest European recommendations of the European Societies of Gynecological Oncology (ESGO), Radiotherapy and Oncology (ESTRO) and Anatomopathology (ESP) concerning the management of patients with endometrial cancer were published in 2021. On behalf of the French Society of Gynecologic Oncology (SFOG) and the SFOG campus, we wish to summarize for the French-speaking readership the main measures with a more specific application for France. We also incorporate data from a Delphi survey conducted with a panel of French and French-speaking Swiss experts. The data presented in this article relate to histo-molecular characteristics, radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, and metastatic cancers. The aim of this review article is to show the application of the latest international recommendations to clinicians and pathologists for the implementation of these recommendations.

Titre traduit de la contribution	Application en France des recommandations européennes 2021 sur le cancer de l'endomètre
langue originale	Anglais
Pages (de - à)	55-68
Nombre de pages	14
journal	Bulletin du Cancer
Volume	110
Numéro de publication	1
Les DOIs	https://doi.org/10.1016/j.bulcan.2022.11.003
état	Publié - 1 janv. 2023
Modification externe	Oui

Accès au document

10.1016/j.bulcan.2022.11.003

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{f400463914ad41aeb28a53c55f54b1a2,

title = "Application in France of the 2021 European recommendations on endometrial cancer",

abstract = "The latest European recommendations of the European Societies of Gynecological Oncology (ESGO), Radiotherapy and Oncology (ESTRO) and Anatomopathology (ESP) concerning the management of patients with endometrial cancer were published in 2021. On behalf of the French Society of Gynecologic Oncology (SFOG) and the SFOG campus, we wish to summarize for the French-speaking readership the main measures with a more specific application for France. We also incorporate data from a Delphi survey conducted with a panel of French and French-speaking Swiss experts. The data presented in this article relate to histo-molecular characteristics, radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, and metastatic cancers. The aim of this review article is to show the application of the latest international recommendations to clinicians and pathologists for the implementation of these recommendations.",

keywords = "Endometrial cancer, European, Guidelines, Molecular analysis",

author = "{groupe SFOG et SFOG campus} and Elise Deluche and Carolin Marti and Floriane Jochum and Sofiane Bendifallah and Henri Aza{\"i}s and Jonas Deidier and Vincent Cockenpot and In{\`e}s Menoux and Manon Kissel and Vincent Balaya and Sarah Betrian and Patrice Mathevet and Cyrus Chargari and Sebastien Gouy and Catherine Genestie and Catherine Uzan and Mojgan Devouassoux-Shisheboran and Frederic Guyon and Cherif Akladios and No{\'e}mie Body and Benedetta Guani",

note = "Publisher Copyright: {\textcopyright} 2022 Soci{\'e}t{\'e} Fran{\c c}aise du Cancer",

year = "2023",

month = jan,

day = "1",

doi = "10.1016/j.bulcan.2022.11.003",

language = "English",

volume = "110",

pages = "55--68",

journal = "Bulletin du Cancer",

issn = "0007-4551",

number = "1",

}

TY - JOUR

T1 - Application in France of the 2021 European recommendations on endometrial cancer

AU - groupe SFOG et SFOG campus

AU - Deluche, Elise

AU - Marti, Carolin

AU - Jochum, Floriane

AU - Bendifallah, Sofiane

AU - Azaïs, Henri

AU - Deidier, Jonas

AU - Cockenpot, Vincent

AU - Menoux, Inès

AU - Kissel, Manon

AU - Balaya, Vincent

AU - Betrian, Sarah

AU - Mathevet, Patrice

AU - Chargari, Cyrus

AU - Gouy, Sebastien

AU - Genestie, Catherine

AU - Uzan, Catherine

AU - Devouassoux-Shisheboran, Mojgan

AU - Guyon, Frederic

AU - Akladios, Cherif

AU - Body, Noémie

AU - Guani, Benedetta

PY - 2023/1/1

Y1 - 2023/1/1

N2 - The latest European recommendations of the European Societies of Gynecological Oncology (ESGO), Radiotherapy and Oncology (ESTRO) and Anatomopathology (ESP) concerning the management of patients with endometrial cancer were published in 2021. On behalf of the French Society of Gynecologic Oncology (SFOG) and the SFOG campus, we wish to summarize for the French-speaking readership the main measures with a more specific application for France. We also incorporate data from a Delphi survey conducted with a panel of French and French-speaking Swiss experts. The data presented in this article relate to histo-molecular characteristics, radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, and metastatic cancers. The aim of this review article is to show the application of the latest international recommendations to clinicians and pathologists for the implementation of these recommendations.

AB - The latest European recommendations of the European Societies of Gynecological Oncology (ESGO), Radiotherapy and Oncology (ESTRO) and Anatomopathology (ESP) concerning the management of patients with endometrial cancer were published in 2021. On behalf of the French Society of Gynecologic Oncology (SFOG) and the SFOG campus, we wish to summarize for the French-speaking readership the main measures with a more specific application for France. We also incorporate data from a Delphi survey conducted with a panel of French and French-speaking Swiss experts. The data presented in this article relate to histo-molecular characteristics, radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, and metastatic cancers. The aim of this review article is to show the application of the latest international recommendations to clinicians and pathologists for the implementation of these recommendations.

KW - Endometrial cancer

KW - European

KW - Guidelines

KW - Molecular analysis

UR - http://www.scopus.com/inward/record.url?scp=85146065808&partnerID=8YFLogxK

U2 - 10.1016/j.bulcan.2022.11.003

DO - 10.1016/j.bulcan.2022.11.003

M3 - Review article

C2 - 36462971

AN - SCOPUS:85146065808

SN - 0007-4551

VL - 110

SP - 55

EP - 68

JO - Bulletin du Cancer

JF - Bulletin du Cancer

IS - 1

ER -